CompletedNCT01539941
Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care
Behavioural studyAges 13–17United States
Understand this study
Who was this study for?
Listed age limits: 13 years to 17 years.
- Listed locations
- New York, United StatesSee all locations and recruitment
- Activities
- Behavioural activities described in the protocol
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateAugust 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 14
- Sponsor
- The National Center on Addiction and Substance Abuse at Columbia University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 13 Years to 17 Years
- Official registry ID
- NCT01539941
- Official title
Show the full official title
Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care
Recruitment & locations
CompletedNew York
Questions about this study
Who is behind this study?
The study sponsor is The National Center on Addiction and Substance Abuse at Columbia University, a university.
Who was this study for?
Listed age limits: 13 years to 17 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
A Novel fNIRS Neurofeedback Intervention for Enhancement of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)
A Peer-Delivered High School Preparatory Intervention for Students With ADHD